论文部分内容阅读
目的观察急性心肌梗死(AMI)心跳骤停患者心肺复苏后静脉尿激酶溶栓的临床疗效。方法 30例急性心肌梗死并发心脏骤停患者心肺复苏后即刻静脉滴注尿激酶150万U溶栓治疗。结果再通率明显高于普通溶栓组,病死率及并发症相对降低。结论 AMI患者心肺复苏后进行溶栓治疗,再通率高、病死率及并发症少,且不增加继发出血发生率。
Objective To observe the clinical efficacy of intravenous urokinase thrombolysis after cardiopulmonary resuscitation in patients with acute myocardial infarction (AMI). Methods 30 cases of acute myocardial infarction with cardiac arrest patients immediately after cardiopulmonary resuscitation intravenous infusion of urokinase 1.5 million U thrombolysis. The recanalization rate was significantly higher than that of the general thrombolytic group, and the mortality and complications were relatively decreased. Conclusion AMI patients after cardiopulmonary resuscitation thrombolytic therapy, and then high pass rate, mortality and complications less, and does not increase the incidence of secondary bleeding.